Atlas Trials

A Phase II Study of QL1706 and Platinum-Based Chemotherapy in Patients With SMARCA4-Deficient, Locally Advanced or Metastatic Non-Small Cell Lung Cancer.

Clinical trial NCT07200947 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07200947
Sponsor
Zhijie Wang
Status
NOT_YET_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
SMARCA4-Deficient TumorLocally Advanced or Metastatic Non-Small Cell Lung Cancer
Start date
2025-12-01
Primary completion
2027-12-01
Enrollment
28

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.